ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements with these filters
Sai Life Sciences Limited has announced the allotment of equity shares under its ESOP scheme. This allotment increases the company's paid-up share capital.
Sai Life Sciences allotted 24,000 shares upon exercise of ESOP 2008 options at ₹188.90 per share. This issuance increases the company's paid-up equity share capital.
Sai Life Sciences summarised proceedings of its 27th AGM held 17 Sep 2026. Shareholders adopted FY25-26 financials and re-appointed MD Krishnamraju Kanumuri.
Sai Life Sciences Limited allotted 80,600 equity shares under its ESOP/ESPS scheme. This increased the company's total paid-up share capital to ₹21.24 Crore.
Sai Life Sciences Limited allotted 80,600 equity shares following the exercise of options under its 2008 and 2018 ESOP plans. The total paid-up capital increased to ₹21.24 Crore.
Sai Life Sciences submitted its Business Responsibility and Sustainability Report (BRSR) and ESG Databook for the financial year 2025-26, as required by regulatory norms.
Sai Life Sciences has filed its Integrated Annual Report for FY 2025-26, including the notice for the 27th AGM scheduled on September 17, 2026.
Sai Life Sciences Limited scheduled its 27th Annual General Meeting for September 17, 2026. The company set September 10, 2026, as the cut-off date for e-voting.
Sai Life Sciences Limited filed its Monitoring Agency Report for the quarter ended 30 June 2026 regarding its IPO proceeds utilization.